Wenquan Niu1, Yi Zhang, Kaida Ji, Mingliang Gu, Pingjin Gao, Dingliang Zhu. 1. State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Ruijin Second Road 197, Shanghai 200025, China. niuwenquan@yahoo.cn
Abstract
BACKGROUND: Confirmation of genome wide association (GWA) results in independent samples has recently become new research tendency. METHODS: We focused on 8 positive top polymorphisms identified in the to-date largest hypertension GWA study and determined whether these polymorphisms were associated with hypertension among Han Chinese. Genotyping was performed among 548 patients diagnosed with essential hypertension and 560 age- and gender-matched controls using ligase detection reactions method. Statistical analyses were conducted using Logistic regression and genotype risk score. RESULTS: Except for a rare polymorphism (rs653178), no deviation from Hardy-Weinberg equilibrium was observed for genotype distributions of others. There was significant differences in the genotype/allele distribution (P=0.006/P=0.002) of rs16998073 in FGF5 (fibroblast growth factor 5) upstream and the allele distribution (P=0.037) of rs16948048 in ZNF652 (zinc finger protein 652) upstream between hypertensive patients and controls. Strong significance was also noted under assumption of different genetic models for the two coalescent polymorphisms, even after controlling covariates of interest. For example, rs16998073 had a 72% increased risk for hypertension under the co-dominant model (95% confidence interval: 1.20-2.45; P=0.003). However, construction of genetic risk scores on common polymorphisms did not reveal any significance with both hypertension and blood pressure, suggesting that contribution of these polymorphisms to hypertension moderate or small in magnitude. CONCLUSIONS: Our results implicate variation in FGF5 and ZNF652 gene upstream regions with altered susceptibility to hypertension in Han Chinese. Copyright 2010 Elsevier B.V. All rights reserved.
BACKGROUND: Confirmation of genome wide association (GWA) results in independent samples has recently become new research tendency. METHODS: We focused on 8 positive top polymorphisms identified in the to-date largest hypertension GWA study and determined whether these polymorphisms were associated with hypertension among Han Chinese. Genotyping was performed among 548 patients diagnosed with essential hypertension and 560 age- and gender-matched controls using ligase detection reactions method. Statistical analyses were conducted using Logistic regression and genotype risk score. RESULTS: Except for a rare polymorphism (rs653178), no deviation from Hardy-Weinberg equilibrium was observed for genotype distributions of others. There was significant differences in the genotype/allele distribution (P=0.006/P=0.002) of rs16998073 in FGF5 (fibroblast growth factor 5) upstream and the allele distribution (P=0.037) of rs16948048 in ZNF652 (zinc finger protein 652) upstream between hypertensivepatients and controls. Strong significance was also noted under assumption of different genetic models for the two coalescent polymorphisms, even after controlling covariates of interest. For example, rs16998073 had a 72% increased risk for hypertension under the co-dominant model (95% confidence interval: 1.20-2.45; P=0.003). However, construction of genetic risk scores on common polymorphisms did not reveal any significance with both hypertension and blood pressure, suggesting that contribution of these polymorphisms to hypertension moderate or small in magnitude. CONCLUSIONS: Our results implicate variation in FGF5 and ZNF652 gene upstream regions with altered susceptibility to hypertension in Han Chinese. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: Zheng Liu; Han Qi; Bin Liu; Kuo Liu; Jingjing Wu; Han Cao; Jie Zhang; Yuxiang Yan; Yan He; Ling Zhang Journal: Hypertens Res Date: 2017-04-27 Impact factor: 3.872
Authors: Mervi Oikonen; Emmi Tikkanen; Jonna Juhola; Tarja Tuovinen; Ilkka Seppälä; Markus Juonala; Leena Taittonen; Vera Mikkilä; Mika Kähönen; Samuli Ripatti; Jorma Viikari; Terho Lehtimäki; Aki S Havulinna; Frank Kee; Christopher Newton-Cheh; Leena Peltonen; Nicholas J Schork; Sarah S Murray; Gerald S Berenson; Wei Chen; Sathanur R Srinivasan; Veikko Salomaa; Olli T Raitakari Journal: Hypertension Date: 2011-10-24 Impact factor: 10.190
Authors: Y L Wang; Y Qi; J N Bai; Z M Qi; J R Li; H Y Zhao; Y F Wang; C Z Lu; Y Xiao; N Jia; B Wang; W Q Niu Journal: J Hum Hypertens Date: 2014-01-16 Impact factor: 3.012
Authors: B Xi; Y Shen; X Zhao; G R Chandak; H Cheng; D Hou; Y Li; J Ott; Y Zhang; X Wang; J Mi Journal: J Hum Hypertens Date: 2013-06-13 Impact factor: 3.012
Authors: Melvin T Korkor; Fan Bo Meng; Shen Yang Xing; Mu Chun Zhang; Jin Rui Guo; Xiao Xue Zhu; Ping Yang Journal: Int J Med Sci Date: 2011-02-27 Impact factor: 3.738